Continuous processing, or flow chemistry, has been used for decades in the chemical industry. However, the pharmaceutical industry has relied on batch processing to manufacture drug products for decades. Recently, continuous flow chemistry (e.g. the use of micro flow reactors) has been gaining interest in the pharmaceutical and fine chemical industries due to the inherent increased safety, improved product quality and cost efficiency, and overall production flexibility. Many contract manufacturing organizations (CMOs) offer continuous flow chemistry, but few have the technical capabilities to develop active pharmaceutical ingredients (API) which help customers take full advantage of the technology.  Find globally leading, cGMP compliant Contract Manufacturing Organizations (CMO) and Contract Manufacturing Development Organizations (CDMO) which use advanced continuous flow chemistry techniques to manufacture APIs and fine chemical intermediates by using our free-access database on PharmaCompass. Flow technology was introduced to the pharmaceutical manufacturing in the early 2000s and is now becoming a preferred option for many new chemical entities (NCEs) which are being developed.